Multidisciplinary Research Collaboration in Colorectal Cancer and Peritoneal Metastasis

Professor Hui Wang’s published work connects colorectal and peritoneal disease research with imaging, pathology, molecular investigation and materials science.

Research explores disease affecting the lining and surfaces within the abdomen. Clear anatomical context helps you understand the questions being investigated.

Tissue and molecular studies add different kinds of information. Their relevance to an individual patient depends on the study population, evidence and clinical assessment.

Explore research into imaging, molecular markers and approaches to assessing disease that may be difficult to identify.

Learn how researchers study tumour characteristics, molecular findings and outcomes to understand treatment selection.

Discover research addressing bowel function, surgical complications and tissue repair beyond tumour control.

Understand how consultation differs from research participation, and what needs to be confirmed before joining a study.

Surgical research examines disease assessment, treatment sequencing, patient selection and outcomes after an operation.

Oncology research explores how drug treatments and surgical approaches may fit together, and how outcomes differ between patient groups.

Researchers investigate whether information from medical images and analytical models can improve assessment of peritoneal metastasis.

Studies of tumour tissue examine whether microscopic features provide additional information about disease behaviour and prognosis.

Molecular research investigates tumour-related DNA and other biological features that may explain disease behaviour or support future assessment methods.

Biomaterials research explores materials for tissue repair, wound management and local delivery of therapeutic agents.

The publication list includes development and validation of an image-based deep learning algorithm for detecting synchronous peritoneal metastasis in colorectal cancer. The question is whether computer-assisted analysis can identify useful information within medical images. A published algorithm does not establish routine availability or suitability for an individual scan.

A prospective study investigated cell-free DNA in peritoneal lavage fluid as a possible marker of colorectal cancer spread to the peritoneum. Its final analysis included 51 patients at one institution. Findings were promising but require further validation. The abdominal fluid was collected through a clinical procedure; this is not an ordinary blood test.

Other studies examine risk factors and prediction models, including disease not apparent during initial assessment. Models study patterns across patient groups; they cannot independently confirm or exclude disease in one person.

Published work examines BRAF mutation and molecular status in colorectal cancer with peritoneal metastasis. These studies investigate how biological differences relate to outcomes and surgical treatment. They do not establish a universal rule for everyone with the same molecular finding.

The supplied research record lists clinical studies examining systemic treatment and cytoreductive surgery in different settings. These projects address sequencing and patient selection. The record does not confirm current recruitment or establish results for every listed project.

A JAMA Surgery study examined a pathomics signature in stage III colon cancer and its relationship with prognosis and chemotherapy benefit. This was a retrospective study in a different disease setting; its findings should not be directly applied to patients with peritoneal metastasis.

A study developed and validated a model for bowel dysfunction after rectal cancer resection following radiotherapy. This addresses how treatment may affect everyday function. Findings relate to that specific setting, not every colorectal operation.

Other publications investigate anastomotic leakage, collagen changes and infection after ileostomy reversal. These studies involve different procedures and patient groups. They should not be interpreted as a promise that complications can be prevented.

Research on hydrogels, patches and other materials explores tissue adhesion, wound healing and abdominal wall repair. Whether a material is approved, available or appropriate for clinical use requires separate confirmation.

Investigates mechanisms, material properties or experimental approaches. It does not establish that an approach is proven effective and safe for routine patient care.

Studies a test or model in a defined patient group. It does not establish equal performance in every population or replacement of existing assessment methods.

Examines treatment questions in human participants. A publication does not establish that a study is recruiting or that every patient is eligible.

Applies clinical judgment and relevant evidence to a person’s circumstances. It does not guarantee an outcome or automatic access to experimental approaches.

His documented interests include the development of colorectal peritoneal metastasis, diagnostic assessment, treatment strategies, postoperative complications and biomaterials.

Publications connect clinical research with pathology, imaging analysis, molecular investigation and materials science.

Development and Validation of an Image-based Deep Learning Algorithm for Detection of Synchronous Peritoneal Carcinomatosis in Colorectal Cancer. Investigates computational image analysis for detection; does not establish routine availability or replace clinical interpretation.

Peritoneal cell-free DNA as a sensitive biomarker for detection of peritoneal metastasis in colorectal cancer. A prospective diagnostic study with 51 patients in the final analysis at one institution. Further validation is needed; the specimen is peritoneal lavage fluid, not an ordinary blood sample.

Pathomics Signature for Prognosis and Chemotherapy Benefits in Stage III Colon Cancer. Investigates quantitative pathology features. Retrospective stage III colon cancer findings cannot be directly applied to peritoneal metastasis.

Development and Validation of a Post-Radiotherapy Prediction Model for Bowel Dysfunction After Rectal Cancer Resection. Addresses functional outcomes in a defined treatment setting. Individual relevance requires clinical interpretation.

Effect of BRAF mutation on the prognosis for patients with colorectal cancer undergoing cytoreductive surgery for synchronous peritoneal metastasis. Examines a molecular feature in a specific surgical group. A molecular result alone is not a complete assessment of suitability or personal prognosis.

Injectable Functional Porous Carbon-Loaded Hydrogel with Long-Term Retention and Synergistic Anti-Tumor Properties for Tumor Therapy. Explores local delivery and sustained retention of therapeutic components. Publication does not establish an approved or available treatment through medChina.

Start by asking about consultation arrangements: the relevant clinical service, appointment process and information required through the institution’s approved process. Contacting medChina does not confirm an appointment with Professor Hui Wang, access to a test or eligibility for treatment.

Participation depends on an open study, its criteria and the research team’s assessment. Request the registration, participating institution, recruitment status, requirements, risks and costs before making plans. The supplied documents do not establish current recruitment or international eligibility.

Professional enquiries may describe a proposed question, relevant discipline and intended form of collaboration. Any collaboration requires confirmation by the researchers and institutions. This page does not establish an institutional partnership.

A published result does not establish that an approach is available or appropriate for you. Discuss the study setting and the limits of the evidence.

Study availability, eligibility and participation require separate confirmation. An enquiry does not secure a place in a study.

Ask about communication, coordination and costs before making travel plans. Arrangements depend on the confirmed service.

Share your name, email and the purpose of your enquiry. You may include your country or region and preferred language. Please do not send medical records here.

Discuss whether your request concerns consultation, research information or professional collaboration, and clarify the appropriate next contact.

Confirm the responsible institution, availability, process and any costs before making appointments or travel plans. An enquiry does not guarantee consultation, treatment or research participation.